Transmuscular Quadratus Lumborum Block for Postoperative Pain After Laparoscopic Adrenalectomy
1 other identifier
interventional
72
1 country
1
Brief Summary
This prospective, randomized control study aims to compare the analgesic effect, satisfaction with anesthesia and analgesia between single-injection QLB (quadratus lumborum block)+general anesthesia (GA) and general anesthesia (GA) alone in patients undergoing laparoscopic adrenalectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2019
CompletedFirst Posted
Study publicly available on registry
May 8, 2019
CompletedStudy Start
First participant enrolled
May 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 28, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2019
CompletedJanuary 2, 2020
December 1, 2019
4 months
May 7, 2019
December 31, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the NRS pain scores on activity 12-hours after surgery
The NRS (a number scale from 0 to 10) is a commonly used pain intensity rating tool
12-hours after surgery
Secondary Outcomes (7)
the pain scores at rest determined by the numeric rating scale (NRS, 0-10)
At 2,4, 8, 12, 24 ,48,72 hours after the surgery
incidence of postoperative nausea and vomiting (PONV)
within 24 postoperative hours
ambulation time
within 5 days after surgery
time of recovery of bowel movement
within 5 days after surgery
postoperative length of hospital stay
up to 2 weeks after surgery
- +2 more secondary outcomes
Study Arms (2)
single-injection QLB (quadratus lumborum block)
EXPERIMENTALSingle-injection of QLB with local anesthetic is given preoperatively
Placebo control
PLACEBO COMPARATORSingle-injection of QLB with NS is given preoperatively
Interventions
Inject 0.4ml/kg 0.5% ropivacaine between quadratus lumborum and psoas major muscle Device: The curved (C1-5) probe of Ultrasound Scanner Philips CX50 is used for scan Drug: single dose ropivacaine 0.4ml/kg 0.5% ropivacaine is given immediately after the correct position of needle tip is verified.
Inject 0.4ml/kg saline between quadratus lumborum and psoas major muscle Device: The curved (C1-5) probe of Ultrasound Scanner Philips CX50 is used for scan Drug: single dose 0.4ml/kg 0.9% NS is given immediately after the correct position of the needle tip is verified
Eligibility Criteria
You may qualify if:
- Age 18-70 yrs
- American Society of Anesthesiologists physical statusⅠ-Ⅲ
- Undergo laparoscopic adrenalectomy
- Informed consent
You may not qualify if:
- a known allergy to the medications being used for anesthesia
- coagulopathy or on anticoagulants
- chronic opioid therapy or history of substance abuse
- participating in another RCT
- inability to properly describe postoperative pain to investigators (e.g., language barrier, neuropsychiatric disorder).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking Union Medical College Hospital
Beijing, China
Related Publications (1)
Yuan Q, Lu S, Cui X, Zhang Y, Xie Y, Zhang Y, Yan W, Ji Z, Huang Y. Transmuscular quadratus lumborum block for postoperative pain and recovery after laparoscopic adrenalectomy: a randomized controlled trial. BMC Anesthesiol. 2021 Nov 9;21(1):274. doi: 10.1186/s12871-021-01494-4.
PMID: 34753425DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yuguang Huang
PUMCH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
May 7, 2019
First Posted
May 8, 2019
Study Start
May 10, 2019
Primary Completion
August 28, 2019
Study Completion
September 2, 2019
Last Updated
January 2, 2020
Record last verified: 2019-12